Search for " " - 2/478

Results for “ ”

Entry	Author	Date	Location
Celgene to Sell Blockbuster Drug to Amgen for $13B to Close BMS Deal	Frank Vinluan	08/26/19	New York
For GW Pharma CEO Justin Gover, The CBD Trend Started 20 Years Ago	Sarah de Crescenzo	08/26/19	San Diego
New PCSK9 Cholesterol Drug Faces Tough Foe. (Hint: Not Cholesterol.)	Alex Lash	08/26/19	National
GSK’s Cancer Comeback Continues With Data for Multiple Myeloma Drug	Frank Vinluan	08/23/19	National
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More	Frank Vinluan	08/23/19	National
New BC Biotech Chinook Reels in $65M to Tackle Kidney Disease	Sarah de Crescenzo	08/22/19	National
Retrophin Sinks as Drug “Pharma Bro” Martin Shkreli Co-Invented Fails	Ben Fidler	08/22/19	San Diego
Healthcare’s Future is Telemedicine & AI, But Will Everyone Benefit?	Jeff Bauter Engel	08/22/19	Boston
Xcelerate at Biotech Week Boston Discount Ticket Sale Ends Friday	Editors	08/21/19	National
Oncorus Adds $79.5M to Steer Cancer-Fighting Virus to Human Testing	Frank Vinluan	08/21/19	Boston
Elanco’s $7.6B Deal With Bayer Bolsters Pets, Farm Animals Footprint	Frank Vinluan	08/20/19	Indiana
FDA Rejects Sarepta’s Second Duchenne Drug, Citing Safety Concerns	Ben Fidler	08/19/19	Boston
Pfizer Spinout SpringWorks, Migraine Drug Firm Satsuma Prep IPOs	Frank Vinluan	08/16/19	New York
AbbVie’s Successor to Humira Wins FDA OK for Rheumatoid Arthritis	Sarah de Crescenzo	08/16/19	National
Bio Roundup: Zolgensma Fallout, Duchenne Redux, Ebola Boost & More	Alex Lash	08/16/19	National
Motif Unveils New Name and $27.5M to Build Food Ingredients Pipeline	Frank Vinluan	08/15/19	Boston
Four New Drugs Are Around the Corner. Here’s What You Need to Know.	Ben Fidler	08/15/19	National
Genomics Experts Preview Xconomy’s Aug. 27 Bay Area Biotech Forum	Editors	08/14/19	National
Chasing Blueprint, Deciphera Plans FDA Filing for GI Cancer Drug	Ben Fidler	08/13/19	Boston
Vor Biopharma Appoints Neon’s Robert Ang President & CEO	Frank Vinluan	08/12/19	Boston
Bio Roundup: Surprise News, a Gene Therapy Mess & a CAR-T Step	Ben Fidler	08/09/19	National
Bayer Buys Out BlueRock, Betting at Least $240M More on Cell Therapy Work	Ben Fidler	08/08/19	Boston
Organovo Halts Liver Tissue R&D, Plans Restructuring to Cut Costs	Sarah de Crescenzo	08/07/19	San Diego
Rhythm Pharma’s Obesity Drug Hits Phase 3 Goals, FDA Filing Planned	Frank Vinluan	08/07/19	Boston
AIQ Solutions Hits On $3.2M to Pinpoint Drug-Resistant Tumors	Jeff Bauter Engel	08/07/19	Wisconsin
Turning Genomics Into Better Health on Aug. 27: Early Bird Rate Ends Soon	Ashley Gentile	08/07/19	San Francisco
Women’s Health-Focused Luca Bio Takes Microbiome R&D Beyond the Gut	Sarah de Crescenzo	08/06/19	Boston
FDA: Despite “Manipulated” Data, $2M Gene Therapy Should Stay on Market	Ben Fidler	08/06/19	National
Inari Reaps $89M and Eyes Global Farm Markets for Gene-Edited Seeds	Frank Vinluan	08/06/19	Boston
Another Delay for Intra-Cellular as FDA Extends Review of Psych Drug	Frank Vinluan	08/05/19	New York
Page 2 of 376	« previous page · next page »